Skip to main content
Top
Published in: Inflammation 1/2015

01-02-2015

Neuroprotective Effect of Humic Acid on Focal Cerebral Ischemia Injury: an Experimental Study in Rats

Authors: Adile Ozkan, Halil Murat Sen, Ibrahim Sehitoglu, Hasan Alacam, Mustafa Guven, Adem Bozkurt Aras, Tarik Akman, Coşkun Silan, Murat Cosar, Handan Isin Ozisik Karaman

Published in: Inflammation | Issue 1/2015

Login to get access

Abstract

Stroke is still a major cause of death and permanent neurological disability. As humic acids are well-known antioxidant molecules, the purpose of this study was to investigate the potential neuroprotective effects of humic acid in a focal cerebral ischemia model. Twenty-four rats were divided equally into three groups. A middle cerebral artery occlusion model was performed in this study where control (group II) and humic acid (group III) were administered intraperitoneally following an ischemic experimental procedure. Group I was evaluated as sham. Malondialdehyde (MDA), superoxide dismutase (SOD), and nuclear respiratory factor-1 (NRF-1) levels were analyzed biochemically on the right side of the ischemic cerebral hemisphere, while ischemic histopathological studies were completed on the left side to investigate the antioxidant status. Biochemical results showed that SOD and NRF-1 levels were significantly increased in the humic acid group (III) compared with the control group (II) while MDA levels were significantly decreased. On histopathological examination, cerebral edema, vacuolization, degeneration, and destruction of neural elements were decreased in the humic acid group (III) compared with the control group (II). Cerebral ischemia was attenuated by humic acid administration. These observations indicate that humic acid may have potential as a therapeutic agent in cerebral ischemia by preventing oxidative stress.
Literature
1.
go back to reference Brouns, R., and P.P. De Deyn. 2009. The complexity of neurological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery 111: 483–495.CrossRefPubMed Brouns, R., and P.P. De Deyn. 2009. The complexity of neurological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery 111: 483–495.CrossRefPubMed
2.
go back to reference Lipton, P. 1999. Ischemic cell death in brain neurons. Physiological Reviews 79: 1431–1568.PubMed Lipton, P. 1999. Ischemic cell death in brain neurons. Physiological Reviews 79: 1431–1568.PubMed
3.
go back to reference Kuroda, S., and B.K. Siesjo. 1997. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clinical Neuroscience 4: 199–212.PubMed Kuroda, S., and B.K. Siesjo. 1997. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clinical Neuroscience 4: 199–212.PubMed
4.
go back to reference Chan, P.H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 21: 2–14.CrossRefPubMed Chan, P.H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 21: 2–14.CrossRefPubMed
5.
go back to reference Zimmermann, C., K. Winnefeld, S. Streck, M. Roskos, R.L. Haberl, et al. 2004. Antioxidant status in acute stroke patients and patients at stroke risk. European Neurology 51: 157–61.CrossRefPubMed Zimmermann, C., K. Winnefeld, S. Streck, M. Roskos, R.L. Haberl, et al. 2004. Antioxidant status in acute stroke patients and patients at stroke risk. European Neurology 51: 157–61.CrossRefPubMed
6.
go back to reference Simonyi, A., Q. Wang, R.L. Miller, et al. 2005. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Molecular Neurobiology 31(1–3): 135–47.CrossRefPubMed Simonyi, A., Q. Wang, R.L. Miller, et al. 2005. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Molecular Neurobiology 31(1–3): 135–47.CrossRefPubMed
7.
go back to reference Gilgun-Sherki, Y., E. Melamed, and D. Offen. 2001. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40: 959–975.CrossRefPubMed Gilgun-Sherki, Y., E. Melamed, and D. Offen. 2001. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40: 959–975.CrossRefPubMed
8.
go back to reference Cho, J.Y., I.S. Kim, Y.H. Jang, et al. 2006. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neuroscience Letters 404: 330–335.CrossRefPubMed Cho, J.Y., I.S. Kim, Y.H. Jang, et al. 2006. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neuroscience Letters 404: 330–335.CrossRefPubMed
9.
10.
go back to reference Chen, Y., J. Katan, A. Gamliel, et al. 2000. Involvement of soluble organic matter in increased plant growth in solarized soils. Biology and Fertility of Soils 32: 28–34.CrossRef Chen, Y., J. Katan, A. Gamliel, et al. 2000. Involvement of soluble organic matter in increased plant growth in solarized soils. Biology and Fertility of Soils 32: 28–34.CrossRef
11.
go back to reference -Gostishcheva M.V.2008. Chemical-pharmaceutical study of native humic acids from peats of Tomsk Oblast, Cand. Sci. Dissertation, Perm -Gostishcheva M.V.2008. Chemical-pharmaceutical study of native humic acids from peats of Tomsk Oblast, Cand. Sci. Dissertation, Perm
12.
go back to reference Van Rensburg, C.E.J., A. Van Straten, and J. Dekker. 2000. An in vitro investigation of the antimicrobial activity of oxifulvic acid. Journal of Antimicrobial Chemotherapy 46: 853–854.CrossRefPubMed Van Rensburg, C.E.J., A. Van Straten, and J. Dekker. 2000. An in vitro investigation of the antimicrobial activity of oxifulvic acid. Journal of Antimicrobial Chemotherapy 46: 853–854.CrossRefPubMed
13.
go back to reference Van Rensburg, C.E.J., S.C.K. Malfield, and J. Dekker. 2001. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Development Research 53: 29–32.CrossRef Van Rensburg, C.E.J., S.C.K. Malfield, and J. Dekker. 2001. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Development Research 53: 29–32.CrossRef
14.
go back to reference Cloete T. E, Swart H, Cronje I. J et al.1990. Oxidized coal products as industrial bactericides. Third International Symposium on Gas, Oil, Coal and Environmental Biotechnology, New Orleans, Louisiana, 3–5 December. Cloete T. E, Swart H, Cronje I. J et al.1990. Oxidized coal products as industrial bactericides. Third International Symposium on Gas, Oil, Coal and Environmental Biotechnology, New Orleans, Louisiana, 3–5 December.
15.
go back to reference Van Rensburg, C.E.J., J. Dekker, R. Weis, et al. 2002. Investigation on the anti-HIV properties of oxihumate. Chemotherapy 48: 138–143.CrossRefPubMed Van Rensburg, C.E.J., J. Dekker, R. Weis, et al. 2002. Investigation on the anti-HIV properties of oxihumate. Chemotherapy 48: 138–143.CrossRefPubMed
16.
go back to reference Thiel, K.D., B. Helbig, R. Klöcking, et al. 1981. Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author’s transl). Pharmazie 36(1): 50–3. German.PubMed Thiel, K.D., B. Helbig, R. Klöcking, et al. 1981. Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author’s transl). Pharmazie 36(1): 50–3. German.PubMed
17.
go back to reference Vucskits, A.V., I. Hullár, A. Bersényi, et al. 2010. Effect of fulvic and humic acids on performance, immune response and thyroid function in rats. Journal of Animal Physiology and Animal Nutrition (Berlin) 94(6): 721–8.CrossRef Vucskits, A.V., I. Hullár, A. Bersényi, et al. 2010. Effect of fulvic and humic acids on performance, immune response and thyroid function in rats. Journal of Animal Physiology and Animal Nutrition (Berlin) 94(6): 721–8.CrossRef
18.
go back to reference Efimova, I.V., S.L. Khil’ko, and O.V. Smirnova. 2012. Antioxidant activity of humic acids in radical-chain oxidation processes. Russian Journal of Applied Chemistry 85(9): 1351–54.CrossRef Efimova, I.V., S.L. Khil’ko, and O.V. Smirnova. 2012. Antioxidant activity of humic acids in radical-chain oxidation processes. Russian Journal of Applied Chemistry 85(9): 1351–54.CrossRef
19.
go back to reference Longa, E.Z., P.R. Weinstein, S. Carlson, et al. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1): 84–91.CrossRefPubMed Longa, E.Z., P.R. Weinstein, S. Carlson, et al. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1): 84–91.CrossRefPubMed
20.
go back to reference Lowry, O.H., N.J. Rosebrough, A.L. Farr, et al. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–75.PubMed Lowry, O.H., N.J. Rosebrough, A.L. Farr, et al. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–75.PubMed
21.
go back to reference Sun, Y., L.W. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.PubMed Sun, Y., L.W. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.PubMed
22.
go back to reference Durak, I., Z. Yurtarslanl, O. Canbolat, et al. 1993. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta 214: 103–4.CrossRef Durak, I., Z. Yurtarslanl, O. Canbolat, et al. 1993. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta 214: 103–4.CrossRef
23.
go back to reference Buege, J.A., and S.D. Aust. 1978. Microsomal lipid peroxidation. Methods in Enzymology 52: 302–10.CrossRefPubMed Buege, J.A., and S.D. Aust. 1978. Microsomal lipid peroxidation. Methods in Enzymology 52: 302–10.CrossRefPubMed
24.
go back to reference Park, H.S., K.H. Han, J.A. Shin, et al. 2014. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. Journal of Korean Neurosurgical Society 55(3): 125–30.CrossRefPubMedCentralPubMed Park, H.S., K.H. Han, J.A. Shin, et al. 2014. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. Journal of Korean Neurosurgical Society 55(3): 125–30.CrossRefPubMedCentralPubMed
25.
go back to reference Bonita, R., S. Mendis, T. Truelsen, et al. 2004. The global stroke initiative. Lancet Neurology 3: 391–393.CrossRef Bonita, R., S. Mendis, T. Truelsen, et al. 2004. The global stroke initiative. Lancet Neurology 3: 391–393.CrossRef
26.
go back to reference Evans, P.H. 1993. Free radicals in brain metabolism and pathology. British Medical Bulletin 49: 577–587.PubMed Evans, P.H. 1993. Free radicals in brain metabolism and pathology. British Medical Bulletin 49: 577–587.PubMed
27.
go back to reference Durukan, A., and T. Tatlisumak. 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology Biochemistry and Behavior 87: 179–197.CrossRef Durukan, A., and T. Tatlisumak. 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology Biochemistry and Behavior 87: 179–197.CrossRef
28.
go back to reference Braughler, J.M., and E.D. Hall. 1989. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biology and Medicine 6: 289–301.CrossRefPubMed Braughler, J.M., and E.D. Hall. 1989. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biology and Medicine 6: 289–301.CrossRefPubMed
29.
go back to reference Bromont, C., C. Marie, and J. Bralet. 1989. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 20(7): 918–24.CrossRefPubMed Bromont, C., C. Marie, and J. Bralet. 1989. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 20(7): 918–24.CrossRefPubMed
30.
go back to reference Zhang, Q., Y. Wu, P. Zhang, et al. 2012. Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 15(205): 10–7.CrossRef Zhang, Q., Y. Wu, P. Zhang, et al. 2012. Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 15(205): 10–7.CrossRef
31.
go back to reference St-Pierre, J., S. Drori, M. Uldry, et al. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2): 397–408.CrossRefPubMed St-Pierre, J., S. Drori, M. Uldry, et al. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2): 397–408.CrossRefPubMed
33.
go back to reference Brzozowski, T., A. Dembiński, and S. Konturek. 1994. Influence of Tołpa Peat Preparation on gastroprotection and on gastric and duodenal ulcers. Acta Poloniae Pharmaceutica 51(1): 103–7.PubMed Brzozowski, T., A. Dembiński, and S. Konturek. 1994. Influence of Tołpa Peat Preparation on gastroprotection and on gastric and duodenal ulcers. Acta Poloniae Pharmaceutica 51(1): 103–7.PubMed
34.
go back to reference Riede, U.N., I. Jonas, B. Kirn, et al. 1992. Collagen stabilization induced by natural humic substances. Archives of Orthopaedic and Trauma Surgery 111(5): 259–64.CrossRefPubMed Riede, U.N., I. Jonas, B. Kirn, et al. 1992. Collagen stabilization induced by natural humic substances. Archives of Orthopaedic and Trauma Surgery 111(5): 259–64.CrossRefPubMed
35.
go back to reference Hu, C.W., C.C. Yen, Y.L. Huang, et al. 2010. Oxidatively damaged DNA induced by humic acid and arsenic in maternal and neonatal mice. Chemosphere 79(1): 93–9.CrossRefPubMed Hu, C.W., C.C. Yen, Y.L. Huang, et al. 2010. Oxidatively damaged DNA induced by humic acid and arsenic in maternal and neonatal mice. Chemosphere 79(1): 93–9.CrossRefPubMed
36.
go back to reference Hseu, Y.C., S.C. Chen, Y.L. Chen, et al. 2008. Humic acid induced genotoxicity in human peripheral blood lymphocytes using comet and sister chromatid exchange assay. Journal of Hazardous Materials 153: 784–791.CrossRefPubMed Hseu, Y.C., S.C. Chen, Y.L. Chen, et al. 2008. Humic acid induced genotoxicity in human peripheral blood lymphocytes using comet and sister chromatid exchange assay. Journal of Hazardous Materials 153: 784–791.CrossRefPubMed
37.
go back to reference Gau, R.J., H.L. Yang, J.L. Suen, et al. 2001. Induction of oxidative stress by humic acid through increasing intracellular iron: a possible mechanism leading to atherothrombotic vascular disorder in blackfoot disease. Biochemical and Biophysical Research Communications 283: 743–749.CrossRefPubMed Gau, R.J., H.L. Yang, J.L. Suen, et al. 2001. Induction of oxidative stress by humic acid through increasing intracellular iron: a possible mechanism leading to atherothrombotic vascular disorder in blackfoot disease. Biochemical and Biophysical Research Communications 283: 743–749.CrossRefPubMed
38.
go back to reference Cheng, M.L., H.Y. Ho, Y.W. Huang, et al. 2003. Humic acid induces oxidative DNA damage, growth retardation, and apoptosis in human primary fibroblasts. Experimental Biology and Medicine (Maywood, N.J.) 228(4): 413–23. Cheng, M.L., H.Y. Ho, Y.W. Huang, et al. 2003. Humic acid induces oxidative DNA damage, growth retardation, and apoptosis in human primary fibroblasts. Experimental Biology and Medicine (Maywood, N.J.) 228(4): 413–23.
39.
go back to reference Cheng, M.L., H.Y. Ho, D.T. Chiu, et al. 1999. Humic acid-mediated oxidative damages to human erythrocytes: a possible mechanism leading to anemia in blackfoot disease. Free Radical Biology and Medicine 27(3–4): 470–477.CrossRefPubMed Cheng, M.L., H.Y. Ho, D.T. Chiu, et al. 1999. Humic acid-mediated oxidative damages to human erythrocytes: a possible mechanism leading to anemia in blackfoot disease. Free Radical Biology and Medicine 27(3–4): 470–477.CrossRefPubMed
40.
go back to reference Kodama, H., and Denso. 2007. Antitumor effect of humus extract on murine transplantable L1210 leukemia. Journal of Veterinary Sciences and Medicine 69: 1069–1071.CrossRef Kodama, H., and Denso. 2007. Antitumor effect of humus extract on murine transplantable L1210 leukemia. Journal of Veterinary Sciences and Medicine 69: 1069–1071.CrossRef
41.
go back to reference Kodama, H., Okazaki F. Denso, and S. Ishida. 2008. Protective effect of humus extract against Trypanosoma brucei infection in mice. Journal of Veterinary Medical Science 70(11): 1185–90.CrossRefPubMed Kodama, H., Okazaki F. Denso, and S. Ishida. 2008. Protective effect of humus extract against Trypanosoma brucei infection in mice. Journal of Veterinary Medical Science 70(11): 1185–90.CrossRefPubMed
42.
go back to reference Joone, G.K., J. Dekker, and C.E. Van Rensburg. 2003. Investigation of the immunostimulatory properties of oxihumate. Zeitschrift fu¨ r Naturforschung. C 58: 263–267. Joone, G.K., J. Dekker, and C.E. Van Rensburg. 2003. Investigation of the immunostimulatory properties of oxihumate. Zeitschrift fu¨ r Naturforschung. C 58: 263–267.
Metadata
Title
Neuroprotective Effect of Humic Acid on Focal Cerebral Ischemia Injury: an Experimental Study in Rats
Authors
Adile Ozkan
Halil Murat Sen
Ibrahim Sehitoglu
Hasan Alacam
Mustafa Guven
Adem Bozkurt Aras
Tarik Akman
Coşkun Silan
Murat Cosar
Handan Isin Ozisik Karaman
Publication date
01-02-2015
Publisher
Springer US
Published in
Inflammation / Issue 1/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-0005-0

Other articles of this Issue 1/2015

Inflammation 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine